All In MedTech

Device Trial Radar · NCT00566943

Reinforcement of Surgical Staple Lines Using Peri-Strips Dry (PSD) With Veritas Collagen Matrix

Synovis Life Technologies, Inc., Peri-Strips Dry With Veritas Collagen Matrix Staple Line Reinforcement. The RESULTS Trial

Last checked: Nov 19, 2026Latest source record: May 19, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 101 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

101

Actual

Start

Mar 2006

Primary completion

Dec 2008

Study completion Dec 2008

Sponsor

Lead sponsor
Baxter Healthcare CorporationPublic (BAX)
Sponsor type
Industry
Collaborators
Synovis Surgical Innovations
First posted
Dec 4, 2007

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to verify the performance of PSD Veritas to provide staple line protection during surgical procedures for obesity.

Conditions

  • Obesity

Interventions

  • PSD Veritas Collagen MatrixDevice

    Roux-en-Y gastric by-pass surgery. Surgeon creates a small pouch from the stomach and then by-passes a large portion of the small intestine. The body cannot absorb as many calories or nutrients thus resulting in weight loss.

  • Roux-en-Y gastric by-pass surgery with no buttressProcedure

    Patients who have laparoscopic Roux-en-Y gastric by-pass surgery without staple line buttress material. No buttress material will be used on staple line including stomach/pouch, anastomostic junctions, (gastrojejunostomy (GJ) gastric to intestine, or jejunojejunostomy (JJ) intestine to intestine intestine to mesentery.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Linear and Circular Arm: Number of Subjects With Major Gastric Related Adverse Events Comparison Between Control and PSD Veritas Groups.Time frame: Discharge/ 30 days Linear Discharge/30/90 days Circular
  2. Linear and Circular Arm: Number of Participants With a Leak as Determined by a Comparison of Control Group to PSD Veritas Group.Time frame: Discharge/30 Linear Discharge/30/90 days Circular

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Missouri-Columbia

    Columbia, Missouri

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.